Sangamo Biosciences, Inc. (NASDAQ:SGMO)

CAPS Rating: 2 out of 5

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.

Recs

0
Player Avatar HealthcareGuy (98.85) Submitted: 7/9/2012 3:35:18 PM : Outperform Start Price: $5.67 SGMO Score: +5.26

some smart money loading into it, and setting up well technically

Featured Broker Partners


Advertisement